Issue 7/2019
Content (11 Articles)
Are All Dopamine Agonists Essentially the Same?
- Idiopathic Parkinson Disease
- Current Opinion
Margherita Torti, Daniele Bravi, Laura Vacca, Fabrizio Stocchi
New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship
- Aztreonam
- Current Opinion
Shio-Shin Jean, Ian M. Gould, Wen-Sen Lee, Po-Ren Hsueh
The Clinician’s Guide to Proton Pump Inhibitor Related Adverse Events
- Proton Pump Inhibitors
- Therapy in Practice
Evan Elias, Laura E. Targownik
The Unique Pharmacological and Pharmacokinetic Profile of Teneligliptin: Implications for Clinical Practice
- Open Access
- Canagliflozin
- Review Article
Antonio Ceriello, Valeria De Nigris, Hiroaki Iijima, Takahiro Matsui, Maki Gouda
Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- Systematic Review
Federica Fogacci, Nicola Ferri, Peter P. Toth, Massimiliano Ruscica, Alberto Corsini, Arrigo F. G. Cicero
Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
- Open Access
- Acute Lymphoblastic Leukemia
- Adis Drug Evaluation
Young-A. Heo, Yahiya Y. Syed, Susan J. Keam
Solriamfetol: First Global Approval
- Maintenance of Wakefulness Test
- AdisInsight Report
Anthony Markham
Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
- Open Access
- Amikacin
- Correction
Matt Shirley
Correction to: Eravacycline: A Review in Complicated Intra-Abdominal Infections
- Open Access
- Correction
Lesley J. Scott